2021. Efficacy of Brodalumab vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post hoc Analysis of Two Phase 3 Psoriasis Studies. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s51. DOI:https://doi.org/10.25251/skin.5.supp.51.